Lymphoma Immunotherapy: Monoclonal Antibodies and Mechanism of Action, Antibody-Drug Conjugates, Immune Checkpoint Inhibitors, Immune-related Adverse Effects, Allogeneic HTC, T-cell Immunotherapy

August 2018

0 Comments
Login to view comments. Click here to Login